Affordable Access

deepdyve-link
Publisher Website

Self-efficacy for symptom management in the acute phase of hematopoietic stem cell transplant: A pilot study.

Authors
  • White, Lynn L1
  • Kupzyk, Kevin A2
  • Berger, Ann M3
  • Cohen, Marlene Z4
  • Bierman, Philip J5
  • 1 College of Nursing, University of Nebraska Medical Center, 985330 Nebraska Medical Center, Omaha, NE, 68198, USA; Avera McKennan Hospital and University Health Center, 1325 S Cliff Ave, Sioux Falls, SD, 57105, USA; Augustana University, 2001 S Summit Ave, Sioux Falls, SD, 57197, USA. Electronic address: [email protected]
  • 2 College of Nursing, University of Nebraska Medical Center, 985330 Nebraska Medical Center, Omaha, NE, 68198, USA. Electronic address: [email protected]
  • 3 College of Nursing, University of Nebraska Medical Center, 985330 Nebraska Medical Center, Omaha, NE, 68198, USA. Electronic address: [email protected]
  • 4 College of Nursing, University of Nebraska Medical Center, 985330 Nebraska Medical Center, Omaha, NE, 68198, USA; VA Nebraska-Western Iowa Health Care System, 4101 Woolworth Ave, Omaha, NE, 68105, USA. Electronic address: [email protected]
  • 5 College of Medicine, University of Nebraska Medical Center, Department of Internal Medicine, Division of Oncology & Hematology, 983332 Nebraska Medical Center, Omaha, NE, 68198, USA. Electronic address: [email protected]
Type
Published Article
Journal
European journal of oncology nursing : the official journal of European Oncology Nursing Society
Publication Date
Jul 17, 2019
Volume
42
Pages
21–27
Identifiers
DOI: 10.1016/j.ejon.2019.07.006
PMID: 31446260
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

Hematopoietic stem cell transplant (HSCT) is an intensive treatment associated with distressing treatment and disease-related symptoms that affect patient outcomes such as functional status and quality of life. Self-efficacy for symptom management (SESM) is a person's belief in their ability to perform behaviors to prevent and relieve symptoms. Presence of SESM can impact symptom distress and functional status. This study describes the changes over time and relationships among SESM, symptom distress, and physical functional status in adults during the acute phase of HSCT. Patients (n = 40) completed measures of symptom distress, SESM, and physical function at time points prior to and at days 7, 15 and 30 post-transplant. Clinical outcomes were length of stay and number of readmissions. Symptom distress, physical function, and SESM changed significantly over time. There was a significant negative relationship between symptom distress and physical function and between symptom distress and SESM at all points. The lowest levels of SESM and physical function were at day 7 when symptom distress was highest. Symptom distress was a moderator for the relationship between physical function and SESM at day 15. This was the first study to examine SESM in the acute phase of HSCT. Higher SESM was associated with fewer symptoms and increased physical function. Less symptom distress was associated with higher physical function and confidence to manage symptoms. These findings provide the basis for development of patient-centered interventions to enhance SESM when symptoms are at their highest immediately after HSCT. Copyright © 2019 Elsevier Ltd. All rights reserved.

Report this publication

Statistics

Seen <100 times